Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies
Abstract Phosphodiesterase (PDE) inhibitors, such as pentoxifylline (PTX), are used as pharmacological agents to enhance sperm motility in assisted reproductive technology (ART), mainly to aid the selection of viable sperm in asthenozoospermic ejaculates and testicular spermatozoa, prior to intracyt...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6b92d4ccba4c4906872030c4e4ff86cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6b92d4ccba4c4906872030c4e4ff86cb |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6b92d4ccba4c4906872030c4e4ff86cb2021-12-02T17:47:03ZStructure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies10.1038/s41598-021-91636-y2045-2322https://doaj.org/article/6b92d4ccba4c4906872030c4e4ff86cb2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91636-yhttps://doaj.org/toc/2045-2322Abstract Phosphodiesterase (PDE) inhibitors, such as pentoxifylline (PTX), are used as pharmacological agents to enhance sperm motility in assisted reproductive technology (ART), mainly to aid the selection of viable sperm in asthenozoospermic ejaculates and testicular spermatozoa, prior to intracytoplasmic sperm injection (ICSI). However, PTX is reported to induce premature acrosome reaction (AR) and, exert toxic effects on oocyte function and early embryo development. Additionally, in vitro binding studies as well as computational binding free energy (ΔGbind) suggest that PTX exhibits weak binding to sperm PDEs, indicating room for improvement. Aiming to reduce the adverse effects and to enhance the sperm motility, we designed and studied PTX analogues. Using structure-guided in silico approach and by considering the physico-chemical properties of the binding pocket of the PDEs, designed analogues of PTX. In silico assessments indicated that PTX analogues bind more tightly to PDEs and form stable complexes. Particularly, ex vivo evaluation of sperm treated with one of the PTX analogues (PTXm-1), showed comparable beneficial effect at much lower concentration—slower AR, higher DNA integrity and extended longevity of spermatozoa and superior embryo quality. PTXm-1 is proposed to be a better pharmacological agent for ART than PTX for sperm function enhancement.Mutyala SatishSandhya KumariWaghela DeekshaSuman AbhishekKulhar NitinSatish Kumar AdigaPadmaraj HegdeJagadeesh Prasad DasappaGuruprasad KalthurEerappa RajakumaraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-17 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Mutyala Satish Sandhya Kumari Waghela Deeksha Suman Abhishek Kulhar Nitin Satish Kumar Adiga Padmaraj Hegde Jagadeesh Prasad Dasappa Guruprasad Kalthur Eerappa Rajakumara Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies |
description |
Abstract Phosphodiesterase (PDE) inhibitors, such as pentoxifylline (PTX), are used as pharmacological agents to enhance sperm motility in assisted reproductive technology (ART), mainly to aid the selection of viable sperm in asthenozoospermic ejaculates and testicular spermatozoa, prior to intracytoplasmic sperm injection (ICSI). However, PTX is reported to induce premature acrosome reaction (AR) and, exert toxic effects on oocyte function and early embryo development. Additionally, in vitro binding studies as well as computational binding free energy (ΔGbind) suggest that PTX exhibits weak binding to sperm PDEs, indicating room for improvement. Aiming to reduce the adverse effects and to enhance the sperm motility, we designed and studied PTX analogues. Using structure-guided in silico approach and by considering the physico-chemical properties of the binding pocket of the PDEs, designed analogues of PTX. In silico assessments indicated that PTX analogues bind more tightly to PDEs and form stable complexes. Particularly, ex vivo evaluation of sperm treated with one of the PTX analogues (PTXm-1), showed comparable beneficial effect at much lower concentration—slower AR, higher DNA integrity and extended longevity of spermatozoa and superior embryo quality. PTXm-1 is proposed to be a better pharmacological agent for ART than PTX for sperm function enhancement. |
format |
article |
author |
Mutyala Satish Sandhya Kumari Waghela Deeksha Suman Abhishek Kulhar Nitin Satish Kumar Adiga Padmaraj Hegde Jagadeesh Prasad Dasappa Guruprasad Kalthur Eerappa Rajakumara |
author_facet |
Mutyala Satish Sandhya Kumari Waghela Deeksha Suman Abhishek Kulhar Nitin Satish Kumar Adiga Padmaraj Hegde Jagadeesh Prasad Dasappa Guruprasad Kalthur Eerappa Rajakumara |
author_sort |
Mutyala Satish |
title |
Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies |
title_short |
Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies |
title_full |
Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies |
title_fullStr |
Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies |
title_full_unstemmed |
Structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies |
title_sort |
structure-based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/6b92d4ccba4c4906872030c4e4ff86cb |
work_keys_str_mv |
AT mutyalasatish structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT sandhyakumari structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT wagheladeeksha structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT sumanabhishek structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT kulharnitin structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT satishkumaradiga structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT padmarajhegde structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT jagadeeshprasaddasappa structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT guruprasadkalthur structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies AT eerapparajakumara structurebasedredesigningofpentoxifyllineanalogsagainstselectivephosphodiesterasestomodulatespermfunctionalcompetenceforassistedreproductivetechnologies |
_version_ |
1718379534078705664 |